Geode Capital Management
KRRO icon

Geode Capital Management’s Korro Bio KRRO Stock Holding History

Geode Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Buy
173,643
+10,883
+7% +$120K ﹤0.01% 3129
2025
Q4 		$1.3M Sell
162,760
-172
-0.1% -$4.02K ﹤0.01% 3298
2025
Q3 		$7.8M Buy
162,932
+7,545
+5% +$167K ﹤0.01% 2557
2025
Q2 		$1.94M Buy
155,387
+15,166
+11% +$218K ﹤0.01% 3155
2025
Q1 		$2.44M Buy
140,221
+3,134
+2% +$92.9K ﹤0.01% 2963
2024
Q4 		$5.22M Sell
137,087
-410
-0.3% -$21.1K ﹤0.01% 2729
2024
Q3 		$4.6M Sell
137,497
-2,161
-2% -$90.9K ﹤0.01% 2804
2024
Q2 		$4.73M Buy
139,658
+81,417
+140% +$4.5M ﹤0.01% 2760
2024
Q1 		$5.24M Buy
58,241
+867
+2% +$47.3K ﹤0.01% 2675
2023
Q4 		$2.75M Buy
57,374
+50,820
+775% +$1.67M ﹤0.01% 2985
2023
Q3 		$120K Buy
6,554
+4
+0.1% +$100 ﹤0.01% 4182
2023
Q2 		$113K Hold
6,550
– – ﹤0.01% 4287
2023
Q1 		$165K Hold
6,550
– – ﹤0.01% 4136
2022
Q4 		$1.26M Buy
6,550
+359
+6% +$36.9K ﹤0.01% 3249
2022
Q3 		$554K Buy
6,191
+193
+3% +$19.6K ﹤0.01% 3671
2022
Q2 		$449K Sell
5,998
-5,804
-49% -$392K ﹤0.01% 3832
2022
Q1 		$1.25M Buy
11,802
+304
+3% +$58.1K ﹤0.01% 3509
2021
Q4 		$2.95M Buy
11,498
+778
+7% +$236K ﹤0.01% 3173
2021
Q3 		$3.78M Sell
10,720
-209
-2% -$82.3K ﹤0.01% 3070
2021
Q2 		$5.44M Buy
10,929
+1,389
+15% +$678K ﹤0.01% 2841
2021
Q1 		$4.53M Buy
9,540
+956
+11% +$1.86M ﹤0.01% 2840
2020
Q4 		$15.1M Buy
8,584
+231
+3% +$305K ﹤0.01% 1889
2020
Q3 		$8.02M Buy
8,353
+3,427
+70% +$3.68M ﹤0.01% 2100
2020
Q2 		$5.73M Buy
4,926
+2,968
+152% +$2.68M ﹤0.01% 2257
2020
Q1 		$1.74M Buy
1,958
+533
+37% +$575K ﹤0.01% 2741
2019
Q4 		$1.25M Buy
+1,425
New +$1.11M ﹤0.01% 3198

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management's KRRO Position: Q1 2026 in Review

Geode Capital Management increased its Korro Bio (KRRO) stake by 6.7% in Q1 2026, buying an estimated $120K and bringing the position to 173,643 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Geode Capital Management first reported a position in KRRO in Q4 2019 and has held it in 26 quarters since. The position peaked at $15.1M in Q4 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Geode Capital Management held 173,643 shares of Korro Bio worth $1.97M as of Q1 2026.
  • Geode Capital Management bought 10,883 Korro Bio shares in Q1 2026, an estimated $120K.
  • Korro Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3129 holding.
  • Geode Capital Management first reported a position in Korro Bio in Q4 2019 and has held it in 26 quarters since.
  • Geode Capital Management's Korro Bio position peaked at $15.1M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.